ars. 
2106. 
pay 2 
218: 
216. 
220. 
221. 
222. 
223. 
224. 
Evans, FRANKLIN T. “The effect of several psychotomimetic drugs on 
human serum cholinesterase.” Psychopharmacologia, Vol I, No 3, 1960, pp 
231-240. [ vi] 
Gdumann, E. “Rauschzustinde nach Pilzgenuss.” Experientia, Vol 15, 
Sept 15 1959, pp 363-364. [vit] 
GeLpke, Rupo_r. “Von Fahrten in den Weltraum der Seele.”’ Antaios, Vol 
3, 1962, pp 393-411. [vu] 
GESSNER, P. K., wiTH P. A. KHAIRALLAH, W. M. McIsAac, AND I. H. PAGE. 
“The relationship between the metabolic rate and pharmacological actions 
of serotonin, bufotenine and psilocybin.” J Pharmacol, Vol 130, Oct 1960, 
pp (26-133. [vi] 
Gipertl, F., AND L. Grecoretti. “Contributo allo studio Psicofarmacolo- 
gico delle depressioni e dell’ansia: Nota II. Ricerche con l’impiego della 
L.A.E. 32 e della psilocibina.” Le sindromi depressive—Atti del Symposium, 
Rapallo, 1960. [vit] 
Gnirss, F, “Untersuchungen mit Psilocybin, einem Phantastikum aus dem 
mexikanischen Rauschpilz Psilocybe mexicana.” Schweiz Arch Neurol 
Psychiat, Vol 84, 1959, p 346-348. [vu] 
Heimann, Hans. “Ausdrucksphanomenologie der Modellpsychosen (Psilo- 
cybin).”’ Psychiat et Neurol, Basel, Vol 141, 1961, pp 69-100. [vit] 
———. “Zur Behandlung therapieresistenter Neurosen mit Modellpsy- 
chosen (Psilocybin),”’ Schweiz Arch Neurol Psychiat, Vol 89, 1962, pp 214- 
220. [vi] 
Henze, C. Recent Progress in Psychopharmacology. A Critique. Paper 
presented at the Meeting of the Arizona Medical Association on May 6 
1960. Mimeographed. [vii] 
Hipatco T., WituaM. “Estudio comparativo psicofisiolégico de la mesca- 
lina, dietilamida del Acido D-lisérgico y psilocybina.”” Acta med venez, Vol 
8, Nos 2-3, 1960, pp 56-62. [vit] 
. HorMaNnn, ALBERT. “Rapport sur une auto-expérience avec le Psilocybe 
mexicana Heim.” See Entry 2, pp 278-280. [vit] 
—, wiTH R. Hei, A. Brack, AND H. Kose. “La psilocybine, principe 
actif psychotrope extrait du champignon hallucinogéne Psilocybe mexicana 
Heim.” See Entry 2, pp 255-257. [v] 
[61] 
